Fund Holdings — Octagon Capital Advisors LP

Total Portfolio Value:
$624.99M
Total Bought:
$94.53M
Total Sold:
$217.45M
Net Transaction:
-$122.92M
Notable People:
Ting (Nmn) Jia, Octagon Capital Advisors, Llc
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Apellis Pharmaceuticals Inc
COM
3,130,0002,806,980-323,020$119.07M$168.03M26.88%+$48.96M
Cymabay Therapeutics Inc3,073,7502,673,750-400,000$45.83M$63.15M10.10%+$17.32M
Verona Pharma PlcADS2,369,0002,369,0000$38.61M$47.10M7.54%+$8.48M
Insmed Incorporated(INSM)1,284,0001,284,0000$32.42M$39.79M6.37%+$7.37M
Arcus Biosciences, Inc.(RCUS)1,968,0001,868,000-100,000$35.33M$35.68M5.71%+$353.2K
BridgeBio Pharma, Inc.(BBIO)971,639706,800-264,839$25.62M$28.53M4.57%+$2.91M
Celldex Therapeutics, Inc.(CLDX)759,898707,526-52,372$20.91M$28.06M4.49%+$7.15M
Roivant Sciences Ltd.SHS(ROIV)4,367,0002,494,000-1,873,000$51.01M$28.01M4.48%-$23.00M
Alpine Immune Sciences Inc750,0001,241,300+491,300$8.59M$23.66M3.79%+$15.07M
Structure Therapeutics IncADS0414,000+414,000$0$16.87M2.70%+$16.87M
Centessa Pharmaceuticals PlcADS475,6002,060,100+1,584,500$3.08M$16.40M2.62%+$13.32M
An2 Therapeutics Inc867,575664,575-203,000$13.95M$13.62M2.18%-$333.5K
Viridian Therapeutics, Inc.(VRDN)1,067,143620,000-447,143$16.37M$13.50M2.16%-$2.87M
Immunovant, Inc.(IMVT)0273,289+273,289$0$11.51M1.84%+$11.51M
Dyne Therapeutics, Inc.(DYN)692,945792,945+100,000$6.21M$10.55M1.69%+$4.34M
Cytokinetics, Incorporated(CYTK)0116,000+116,000$0$9.68M1.55%+$9.68M
Annexon, Inc.(ANNX)2,050,0002,050,0000$4.84M$9.31M1.49%+$4.47M
Aerovate Therapeutics Inc497,370403,685-93,685$6.75M$9.14M1.46%+$2.39M
Gossamer Bio, Inc.(GOSS)8,187,8839,187,883+1,000,000$6.82M$8.38M1.34%+$1.57M
Rapt Therapeutics Inc0292,000+292,000$0$7.26M1.16%+$7.26M
Glycomimetics Inc3,000,0003,000,0000$4.50M$7.08M1.13%+$2.58M
Gracell Biotechnologies IncADS0596,611+596,611$0$5.99M0.96%+$5.99M
Dianthus Therapeutics, Inc.(DNTH)480,000554,000+74,000$6.56M$5.76M0.92%-$800.0K
Reneo Pharmaceuticals Inc2,279,8702,250,000-29,870$17.36M$3.60M0.58%-$13.76M
Jasper Therapeutics, Inc.(JSPR)4,468,1144,468,1140$3.13M$3.53M0.56%+$397.7K
Veru Inc.(VERU)03,800,000+3,800,000$0$2.74M0.44%+$2.74M
Anaptysbio Inc0120,000+120,000$0$2.57M0.41%+$2.57M
Inozyme Pharma Inc1,300,000400,000-900,000$5.46M$1.70M0.27%-$3.76M
Nuvation Bio Inc.CL A(NUVB)01,000,000+1,000,000$0$1.51M0.24%+$1.51M
Xilio Therapeutics, Inc.(XLO)2,318,5001,785,000-533,500$4.89M$981.8K0.16%-$3.91M
Mirum Pharmaceuticals, Inc.(MIRM)025,000+25,000$0$738.0K0.12%+$738.0K
Phathom Pharmaceuticals, Inc.(PHAT)050,000+50,000$0$456.5K0.07%+$456.5K
Aclaris Therapeutics, Inc.(ACRS)0100,000+100,000$0$105.0K0.02%+$105.0K
89BIO INCCOM1,219,1570-1,219,157$18.82M$0—-$18.82M
AMYLYX PHARMACEUTICALS INCCOM(AMLX)695,0000-695,000$12.73M$0—-$12.73M
BIONOMICS LIMITEDADS168,0000-168,000$453.6K$0—-$453.6K
HEPION PHARMACEUTICALS INCCOM NEW(HEPA)67,5000-67,500$336.8K$0—-$336.8K
ITEOS THERAPEUTICS INCCOM102,0000-102,000$1.12M$0—-$1.12M
LEXICON PHARMACEUTICALS INCCOM NEW(LXRX)1,923,0760-1,923,076$2.10M$0—-$2.10M
MIRATI THERAPEUTICS INCCOM655,0510-655,051$28.53M$0—-$28.53M
MONTE ROSA THERAPEUTICS INCCOM(GLUE)812,8950-812,895$3.89M$0—-$3.89M
ORIC PHARMACEUTICALS INCCOM(ORIC)204,5000-204,500$1.24M$0—-$1.24M
PMV PHARMACEUTICALS INCCOM(PMVP)904,0000-904,000$5.55M$0—-$5.55M
TAYSHA GENE THERAPIES INCCOM SHS(TSHA)2,777,7780-2,777,778$8.78M$0—-$8.78M
VIKING THERAPEUTICS INCCOM(VKTX)375,0000-375,000$4.15M$0—-$4.15M
VIR BIOTECHNOLOGY INCCOM(VIR)325,0500-325,050$3.05M$0—-$3.05M
Page 1 of 1
Octagon Capital Advisors LP — 13F Holdings — Q4 2023 | TickerTrail